TickerFacts.

Galmed Pharmaceuticals Ltd. (EOCN): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-15, first reflected in a filing dated 2023-08-09; 1-for-12, first reflected in a filing dated 2025-04-02; 1-for-8, first reflected in a filing dated 2026-09-02. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

6.58M
As of 2025-12-31
25.09M2013-12-31: 9.7K2014-12-31: 11.10M2015-12-31: 11.10M2016-12-31: 12.15M2017-12-31: 14.44M2018-12-31: 21.02M2019-12-31: 21.14M2020-12-31: 21.33M2021-12-31: 25.09M2022-12-31: 1.69M2023-12-31: 573.7K2024-12-31: 1.66M2025-12-31: 6.58M6.58M
2013-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-316.58M+295.3%2026-03-31, Balance as of period end
2024-12-311.66Mn/c2026-03-31, Balance as of period end
2023-12-31573.7Kn/c2025-04-02, Balance as of period end
2022-12-311.69Mn/c2024-04-04, Balance as of period end
2021-12-3125.09M+17.6%2023-03-29, Balance as of period end
2020-12-3121.33M+0.9%2022-05-02, Balance as of period end
2019-12-3121.14M+0.6%2021-03-18, Balance as of period end
2018-12-3121.02Mn/c2020-03-12, Balance as of period end
2017-12-3114.44M+18.8%2019-03-13, Balance as of period end
2016-12-3112.15M+9.4%2018-03-13, Balance as of period end
2015-12-3111.10M0.0%2017-03-23, Balance as of period end
2014-12-3111.10Mn/m2016-03-22, Balance as of period end
2013-12-319.7Kn/a2015-03-31, Balance as of period end